UBC Resource Library

This white paper discusses personalized medicine, applications of pharmacogenetics/pharmacogenomics in oncology and the positive impact they have on drug development.

This white paper offers a comprehensive primer on the burden of SCD, the patient journey, and current and emerging treatment options.

Download our Resource Guide for Patients Living with Rare Diseases to find essential information and support to understand your rare disease diagnosis, connect with advocacy organizations, and explore treatment options.

Learn more about the benefits of natural history studies in drug development.

Learn more about our custom-developed automated solution that can deliver significant cost savings while enhancing the overall quality and efficiency of your case processing.

This white paper provides an essential overview of the regulations, a brief history, and an in-depth look at the EU's Health Technology Assessment Regulation 2021/2282.

Read our white paper to explore how integrating RWD/RWE with clinical trial data can overcome challenges and enhance regulatory submissions.

Read our case study to see how UBC works with you to identify key metrics and ensure that data is provided in a clear and meaningful way.

Learn how the inclusion of real-world data (RWD) and evidence from natural history studies can improve your integrated evidence strategy.